According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period.
The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Contraceptives. Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Contraceptives market.
Methods of contraception include oral contraceptive pills, implants, Injectable, patches, vaginal rings, Intra uterine devices, condoms, male and female sterilization, lactational amenorrhea methods, withdrawal and fertility awareness based methods. These methods have different mechanisms of action and effectiveness in preventing unintended pregnancy.
Europe is the largest Contraceptives market with about 44% market share. North America is follower, accounting for about 37% market share.
The key players are Bayer AG, Pfizer, Inc, Teva Pharmaceutical Industries Ltd, Merck & Co., Inc, Actavis, Inc., Johnson & Johnson, Gedeon Richter, Novo Nordisk A/S, ZiZhu, Baijingyu, Huazhong, Sine etc. Top 3 companies occupied about 46% market share.
Key Features:
The report on Contraceptives market reflects various aspects and provide valuable insights into the industry.
Market Size and Growth: The research report provide an overview of the current size and growth of the Contraceptives market. It may include historical data, market Segmentation by Type (e.g., Pills, Injectable), and regional breakdowns.
Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Contraceptives market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.
Competitive Landscape: The research report provides analysis of the competitive landscape within the Contraceptives market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.
Technological Developments: The research report can delve into the latest technological developments in the Contraceptives industry. This include advancements in Contraceptives technology, Contraceptives new entrants, Contraceptives new investment, and other innovations that are shaping the future of Contraceptives.
Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Contraceptives market. It includes factors influencing customer ' purchasing decisions, preferences for Contraceptives product.
Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Contraceptives market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Contraceptives market. The report also evaluates the effectiveness of these policies in driving market growth.
Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Contraceptives market.
Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Contraceptives industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.
Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Contraceptives market.
Market Segmentation:
Contraceptives market is split by Type and by End User. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by End User in terms of volume and value.
Segmentation by type
- Pills
- Injectable
- Condoms
- Vaginal Rings
- IUDs
- Subdermal Implants
- Others
Segmentation by end user
- 15-24 years
- 25-34 years
- 35-44 years
- Above 44 years
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Bayer AG
- Pfizer, Inc
- Teva Pharmaceutical Industries Ltd
- Merck & Co., Inc
- Actavis, Inc.
- Johnson & Johnson
- Gedeon Richter
- Novo Nordisk A/S
- ZiZhu
- Baijingyu
- Huazhong
- Sine
- Reckitt
- AbbVie
- Church & Dwight
- The Cooper Companies
- TherapeuticsMD
- Afaxys
- Mithra Pharmaceuticals
Key Questions Addressed in this Report
What is the 10-year outlook for the global Contraceptives market?
What factors are driving Contraceptives market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Contraceptives market opportunities vary by end market size?
How does Contraceptives break out type, end user?
Global Contraceptives Market Growth 2024-2030
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Contraceptives Annual Sales 2019-2030
2.1.2 World Current & Future Analysis for Contraceptives by Geographic Region, 2019, 2023 & 2030
2.1.3 World Current & Future Analysis for Contraceptives by Country/Region, 2019, 2023 & 2030
2.2 Contraceptives Segment by Type
2.2.1 Pills
2.2.2 Injectable
2.2.3 Condoms
2.2.4 Vaginal Rings
2.2.5 IUDs
2.2.6 Subdermal Implants
2.2.7 Others
2.3 Contraceptives Sales by Type
2.3.1 Global Contraceptives Sales Market Share by Type (2019-2024)
2.3.2 Global Contraceptives Revenue and Market Share by Type (2019-2024)
2.3.3 Global Contraceptives Sale Price by Type (2019-2024)
2.4 Contraceptives Segment by End User
2.4.1 15-24 years
2.4.2 25-34 years
2.4.3 35-44 years
2.4.4 Above 44 years
2.5 Contraceptives Sales by End User
2.5.1 Global Contraceptives Sale Market Share by End User (2019-2024)
2.5.2 Global Contraceptives Revenue and Market Share by End User (2019-2024)
2.5.3 Global Contraceptives Sale Price by End User (2019-2024)
3 Global Contraceptives by Company
3.1 Global Contraceptives Breakdown Data by Company
3.1.1 Global Contraceptives Annual Sales by Company (2019-2024)
3.1.2 Global Contraceptives Sales Market Share by Company (2019-2024)
3.2 Global Contraceptives Annual Revenue by Company (2019-2024)
3.2.1 Global Contraceptives Revenue by Company (2019-2024)
3.2.2 Global Contraceptives Revenue Market Share by Company (2019-2024)
3.3 Global Contraceptives Sale Price by Company
3.4 Key Manufacturers Contraceptives Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Contraceptives Product Location Distribution
3.4.2 Players Contraceptives Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Contraceptives by Geographic Region
4.1 World Historic Contraceptives Market Size by Geographic Region (2019-2024)
4.1.1 Global Contraceptives Annual Sales by Geographic Region (2019-2024)
4.1.2 Global Contraceptives Annual Revenue by Geographic Region (2019-2024)
4.2 World Historic Contraceptives Market Size by Country/Region (2019-2024)
4.2.1 Global Contraceptives Annual Sales by Country/Region (2019-2024)
4.2.2 Global Contraceptives Annual Revenue by Country/Region (2019-2024)
4.3 Americas Contraceptives Sales Growth
4.4 APAC Contraceptives Sales Growth
4.5 Europe Contraceptives Sales Growth
4.6 Middle East & Africa Contraceptives Sales Growth
5 Americas
5.1 Americas Contraceptives Sales by Country
5.1.1 Americas Contraceptives Sales by Country (2019-2024)
5.1.2 Americas Contraceptives Revenue by Country (2019-2024)
5.2 Americas Contraceptives Sales by Type
5.3 Americas Contraceptives Sales by End User
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Contraceptives Sales by Region
6.1.1 APAC Contraceptives Sales by Region (2019-2024)
6.1.2 APAC Contraceptives Revenue by Region (2019-2024)
6.2 APAC Contraceptives Sales by Type
6.3 APAC Contraceptives Sales by End User
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Contraceptives by Country
7.1.1 Europe Contraceptives Sales by Country (2019-2024)
7.1.2 Europe Contraceptives Revenue by Country (2019-2024)
7.2 Europe Contraceptives Sales by Type
7.3 Europe Contraceptives Sales by End User
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Contraceptives by Country
8.1.1 Middle East & Africa Contraceptives Sales by Country (2019-2024)
8.1.2 Middle East & Africa Contraceptives Revenue by Country (2019-2024)
8.2 Middle East & Africa Contraceptives Sales by Type
8.3 Middle East & Africa Contraceptives Sales by End User
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Contraceptives
10.3 Manufacturing Process Analysis of Contraceptives
10.4 Industry Chain Structure of Contraceptives
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Contraceptives Distributors
11.3 Contraceptives Customer
12 World Forecast Review for Contraceptives by Geographic Region
12.1 Global Contraceptives Market Size Forecast by Region
12.1.1 Global Contraceptives Forecast by Region (2025-2030)
12.1.2 Global Contraceptives Annual Revenue Forecast by Region (2025-2030)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Contraceptives Forecast by Type
12.7 Global Contraceptives Forecast by End User
13 Key Players Analysis
13.1 Bayer AG
13.1.1 Bayer AG Company Information
13.1.2 Bayer AG Contraceptives Product Portfolios and Specifications
13.1.3 Bayer AG Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.1.4 Bayer AG Main Business Overview
13.1.5 Bayer AG Latest Developments
13.2 Pfizer, Inc
13.2.1 Pfizer, Inc Company Information
13.2.2 Pfizer, Inc Contraceptives Product Portfolios and Specifications
13.2.3 Pfizer, Inc Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.2.4 Pfizer, Inc Main Business Overview
13.2.5 Pfizer, Inc Latest Developments
13.3 Teva Pharmaceutical Industries Ltd
13.3.1 Teva Pharmaceutical Industries Ltd Company Information
13.3.2 Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolios and Specifications
13.3.3 Teva Pharmaceutical Industries Ltd Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.3.4 Teva Pharmaceutical Industries Ltd Main Business Overview
13.3.5 Teva Pharmaceutical Industries Ltd Latest Developments
13.4 Merck & Co., Inc
13.4.1 Merck & Co., Inc Company Information
13.4.2 Merck & Co., Inc Contraceptives Product Portfolios and Specifications
13.4.3 Merck & Co., Inc Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.4.4 Merck & Co., Inc Main Business Overview
13.4.5 Merck & Co., Inc Latest Developments
13.5 Actavis, Inc.
13.5.1 Actavis, Inc. Company Information
13.5.2 Actavis, Inc. Contraceptives Product Portfolios and Specifications
13.5.3 Actavis, Inc. Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.5.4 Actavis, Inc. Main Business Overview
13.5.5 Actavis, Inc. Latest Developments
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Information
13.6.2 Johnson & Johnson Contraceptives Product Portfolios and Specifications
13.6.3 Johnson & Johnson Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.6.4 Johnson & Johnson Main Business Overview
13.6.5 Johnson & Johnson Latest Developments
13.7 Gedeon Richter
13.7.1 Gedeon Richter Company Information
13.7.2 Gedeon Richter Contraceptives Product Portfolios and Specifications
13.7.3 Gedeon Richter Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.7.4 Gedeon Richter Main Business Overview
13.7.5 Gedeon Richter Latest Developments
13.8 Novo Nordisk A/S
13.8.1 Novo Nordisk A/S Company Information
13.8.2 Novo Nordisk A/S Contraceptives Product Portfolios and Specifications
13.8.3 Novo Nordisk A/S Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.8.4 Novo Nordisk A/S Main Business Overview
13.8.5 Novo Nordisk A/S Latest Developments
13.9 ZiZhu
13.9.1 ZiZhu Company Information
13.9.2 ZiZhu Contraceptives Product Portfolios and Specifications
13.9.3 ZiZhu Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.9.4 ZiZhu Main Business Overview
13.9.5 ZiZhu Latest Developments
13.10 Baijingyu
13.10.1 Baijingyu Company Information
13.10.2 Baijingyu Contraceptives Product Portfolios and Specifications
13.10.3 Baijingyu Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.10.4 Baijingyu Main Business Overview
13.10.5 Baijingyu Latest Developments
13.11 Huazhong
13.11.1 Huazhong Company Information
13.11.2 Huazhong Contraceptives Product Portfolios and Specifications
13.11.3 Huazhong Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.11.4 Huazhong Main Business Overview
13.11.5 Huazhong Latest Developments
13.12 Sine
13.12.1 Sine Company Information
13.12.2 Sine Contraceptives Product Portfolios and Specifications
13.12.3 Sine Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.12.4 Sine Main Business Overview
13.12.5 Sine Latest Developments
13.13 Reckitt
13.13.1 Reckitt Company Information
13.13.2 Reckitt Contraceptives Product Portfolios and Specifications
13.13.3 Reckitt Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.13.4 Reckitt Main Business Overview
13.13.5 Reckitt Latest Developments
13.14 AbbVie
13.14.1 AbbVie Company Information
13.14.2 AbbVie Contraceptives Product Portfolios and Specifications
13.14.3 AbbVie Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.14.4 AbbVie Main Business Overview
13.14.5 AbbVie Latest Developments
13.15 Church & Dwight
13.15.1 Church & Dwight Company Information
13.15.2 Church & Dwight Contraceptives Product Portfolios and Specifications
13.15.3 Church & Dwight Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.15.4 Church & Dwight Main Business Overview
13.15.5 Church & Dwight Latest Developments
13.16 The Cooper Companies
13.16.1 The Cooper Companies Company Information
13.16.2 The Cooper Companies Contraceptives Product Portfolios and Specifications
13.16.3 The Cooper Companies Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.16.4 The Cooper Companies Main Business Overview
13.16.5 The Cooper Companies Latest Developments
13.17 TherapeuticsMD
13.17.1 TherapeuticsMD Company Information
13.17.2 TherapeuticsMD Contraceptives Product Portfolios and Specifications
13.17.3 TherapeuticsMD Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.17.4 TherapeuticsMD Main Business Overview
13.17.5 TherapeuticsMD Latest Developments
13.18 Afaxys
13.18.1 Afaxys Company Information
13.18.2 Afaxys Contraceptives Product Portfolios and Specifications
13.18.3 Afaxys Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.18.4 Afaxys Main Business Overview
13.18.5 Afaxys Latest Developments
13.19 Mithra Pharmaceuticals
13.19.1 Mithra Pharmaceuticals Company Information
13.19.2 Mithra Pharmaceuticals Contraceptives Product Portfolios and Specifications
13.19.3 Mithra Pharmaceuticals Contraceptives Sales, Revenue, Price and Gross Margin (2019-2024)
13.19.4 Mithra Pharmaceuticals Main Business Overview
13.19.5 Mithra Pharmaceuticals Latest Developments
14 Research Findings and Conclusion
List of Tables
Table 1. Contraceptives Annual Sales CAGR by Geographic Region (2019, 2023 & 2030) & ($ millions)
Table 2. Contraceptives Annual Sales CAGR by Country/Region (2019, 2023 & 2030) & ($ millions)
Table 3. Major Players of Pills
Table 4. Major Players of Injectable
Table 5. Major Players of Condoms
Table 6. Major Players of Vaginal Rings
Table 7. Major Players of IUDs
Table 8. Major Players of Subdermal Implants
Table 9. Major Players of Others
Table 10. Global Contraceptives Sales by Type (2019-2024) & (M Units)
Table 11. Global Contraceptives Sales Market Share by Type (2019-2024)
Table 12. Global Contraceptives Revenue by Type (2019-2024) & ($ million)
Table 13. Global Contraceptives Revenue Market Share by Type (2019-2024)
Table 14. Global Contraceptives Sale Price by Type (2019-2024) & (USD/Unit)
Table 15. Global Contraceptives Sales by End User (2019-2024) & (M Units)
Table 16. Global Contraceptives Sales Market Share by End User (2019-2024)
Table 17. Global Contraceptives Revenue by End User (2019-2024)
Table 18. Global Contraceptives Revenue Market Share by End User (2019-2024)
Table 19. Global Contraceptives Sale Price by End User (2019-2024) & (USD/Unit)
Table 20. Global Contraceptives Sales by Company (2019-2024) & (M Units)
Table 21. Global Contraceptives Sales Market Share by Company (2019-2024)
Table 22. Global Contraceptives Revenue by Company (2019-2024) ($ Millions)
Table 23. Global Contraceptives Revenue Market Share by Company (2019-2024)
Table 24. Global Contraceptives Sale Price by Company (2019-2024) & (USD/Unit)
Table 25. Key Manufacturers Contraceptives Producing Area Distribution and Sales Area
Table 26. Players Contraceptives Products Offered
Table 27. Contraceptives Concentration Ratio (CR3, CR5 and CR10) & (2019-2024)
Table 28. New Products and Potential Entrants
Table 29. Mergers & Acquisitions, Expansion
Table 30. Global Contraceptives Sales by Geographic Region (2019-2024) & (M Units)
Table 31. Global Contraceptives Sales Market Share Geographic Region (2019-2024)
Table 32. Global Contraceptives Revenue by Geographic Region (2019-2024) & ($ millions)
Table 33. Global Contraceptives Revenue Market Share by Geographic Region (2019-2024)
Table 34. Global Contraceptives Sales by Country/Region (2019-2024) & (M Units)
Table 35. Global Contraceptives Sales Market Share by Country/Region (2019-2024)
Table 36. Global Contraceptives Revenue by Country/Region (2019-2024) & ($ millions)
Table 37. Global Contraceptives Revenue Market Share by Country/Region (2019-2024)
Table 38. Americas Contraceptives Sales by Country (2019-2024) & (M Units)
Table 39. Americas Contraceptives Sales Market Share by Country (2019-2024)
Table 40. Americas Contraceptives Revenue by Country (2019-2024) & ($ Millions)
Table 41. Americas Contraceptives Revenue Market Share by Country (2019-2024)
Table 42. Americas Contraceptives Sales by Type (2019-2024) & (M Units)
Table 43. Americas Contraceptives Sales by End User (2019-2024) & (M Units)
Table 44. APAC Contraceptives Sales by Region (2019-2024) & (M Units)
Table 45. APAC Contraceptives Sales Market Share by Region (2019-2024)
Table 46. APAC Contraceptives Revenue by Region (2019-2024) & ($ Millions)
Table 47. APAC Contraceptives Revenue Market Share by Region (2019-2024)
Table 48. APAC Contraceptives Sales by Type (2019-2024) & (M Units)
Table 49. APAC Contraceptives Sales by End User (2019-2024) & (M Units)
Table 50. Europe Contraceptives Sales by Country (2019-2024) & (M Units)
Table 51. Europe Contraceptives Sales Market Share by Country (2019-2024)
Table 52. Europe Contraceptives Revenue by Country (2019-2024) & ($ Millions)
Table 53. Europe Contraceptives Revenue Market Share by Country (2019-2024)
Table 54. Europe Contraceptives Sales by Type (2019-2024) & (M Units)
Table 55. Europe Contraceptives Sales by End User (2019-2024) & (M Units)
Table 56. Middle East & Africa Contraceptives Sales by Country (2019-2024) & (M Units)
Table 57. Middle East & Africa Contraceptives Sales Market Share by Country (2019-2024)
Table 58. Middle East & Africa Contraceptives Revenue by Country (2019-2024) & ($ Millions)
Table 59. Middle East & Africa Contraceptives Revenue Market Share by Country (2019-2024)
Table 60. Middle East & Africa Contraceptives Sales by Type (2019-2024) & (M Units)
Table 61. Middle East & Africa Contraceptives Sales by End User (2019-2024) & (M Units)
Table 62. Key Market Drivers & Growth Opportunities of Contraceptives
Table 63. Key Market Challenges & Risks of Contraceptives
Table 64. Key Industry Trends of Contraceptives
Table 65. Contraceptives Raw Material
Table 66. Key Suppliers of Raw Materials
Table 67. Contraceptives Distributors List
Table 68. Contraceptives Customer List
Table 69. Global Contraceptives Sales Forecast by Region (2025-2030) & (M Units)
Table 70. Global Contraceptives Revenue Forecast by Region (2025-2030) & ($ millions)
Table 71. Americas Contraceptives Sales Forecast by Country (2025-2030) & (M Units)
Table 72. Americas Contraceptives Revenue Forecast by Country (2025-2030) & ($ millions)
Table 73. APAC Contraceptives Sales Forecast by Region (2025-2030) & (M Units)
Table 74. APAC Contraceptives Revenue Forecast by Region (2025-2030) & ($ millions)
Table 75. Europe Contraceptives Sales Forecast by Country (2025-2030) & (M Units)
Table 76. Europe Contraceptives Revenue Forecast by Country (2025-2030) & ($ millions)
Table 77. Middle East & Africa Contraceptives Sales Forecast by Country (2025-2030) & (M Units)
Table 78. Middle East & Africa Contraceptives Revenue Forecast by Country (2025-2030) & ($ millions)
Table 79. Global Contraceptives Sales Forecast by Type (2025-2030) & (M Units)
Table 80. Global Contraceptives Revenue Forecast by Type (2025-2030) & ($ Millions)
Table 81. Global Contraceptives Sales Forecast by End User (2025-2030) & (M Units)
Table 82. Global Contraceptives Revenue Forecast by End User (2025-2030) & ($ Millions)
Table 83. Bayer AG Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 84. Bayer AG Contraceptives Product Portfolios and Specifications
Table 85. Bayer AG Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 86. Bayer AG Main Business
Table 87. Bayer AG Latest Developments
Table 88. Pfizer, Inc Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 89. Pfizer, Inc Contraceptives Product Portfolios and Specifications
Table 90. Pfizer, Inc Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 91. Pfizer, Inc Main Business
Table 92. Pfizer, Inc Latest Developments
Table 93. Teva Pharmaceutical Industries Ltd Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 94. Teva Pharmaceutical Industries Ltd Contraceptives Product Portfolios and Specifications
Table 95. Teva Pharmaceutical Industries Ltd Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 96. Teva Pharmaceutical Industries Ltd Main Business
Table 97. Teva Pharmaceutical Industries Ltd Latest Developments
Table 98. Merck & Co., Inc Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 99. Merck & Co., Inc Contraceptives Product Portfolios and Specifications
Table 100. Merck & Co., Inc Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 101. Merck & Co., Inc Main Business
Table 102. Merck & Co., Inc Latest Developments
Table 103. Actavis, Inc. Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 104. Actavis, Inc. Contraceptives Product Portfolios and Specifications
Table 105. Actavis, Inc. Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 106. Actavis, Inc. Main Business
Table 107. Actavis, Inc. Latest Developments
Table 108. Johnson & Johnson Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 109. Johnson & Johnson Contraceptives Product Portfolios and Specifications
Table 110. Johnson & Johnson Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 111. Johnson & Johnson Main Business
Table 112. Johnson & Johnson Latest Developments
Table 113. Gedeon Richter Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 114. Gedeon Richter Contraceptives Product Portfolios and Specifications
Table 115. Gedeon Richter Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 116. Gedeon Richter Main Business
Table 117. Gedeon Richter Latest Developments
Table 118. Novo Nordisk A/S Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 119. Novo Nordisk A/S Contraceptives Product Portfolios and Specifications
Table 120. Novo Nordisk A/S Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 121. Novo Nordisk A/S Main Business
Table 122. Novo Nordisk A/S Latest Developments
Table 123. ZiZhu Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 124. ZiZhu Contraceptives Product Portfolios and Specifications
Table 125. ZiZhu Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 126. ZiZhu Main Business
Table 127. ZiZhu Latest Developments
Table 128. Baijingyu Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 129. Baijingyu Contraceptives Product Portfolios and Specifications
Table 130. Baijingyu Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 131. Baijingyu Main Business
Table 132. Baijingyu Latest Developments
Table 133. Huazhong Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 134. Huazhong Contraceptives Product Portfolios and Specifications
Table 135. Huazhong Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 136. Huazhong Main Business
Table 137. Huazhong Latest Developments
Table 138. Sine Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 139. Sine Contraceptives Product Portfolios and Specifications
Table 140. Sine Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 141. Sine Main Business
Table 142. Sine Latest Developments
Table 143. Reckitt Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 144. Reckitt Contraceptives Product Portfolios and Specifications
Table 145. Reckitt Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 146. Reckitt Main Business
Table 147. Reckitt Latest Developments
Table 148. AbbVie Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 149. AbbVie Contraceptives Product Portfolios and Specifications
Table 150. AbbVie Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 151. AbbVie Main Business
Table 152. AbbVie Latest Developments
Table 153. Church & Dwight Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 154. Church & Dwight Contraceptives Product Portfolios and Specifications
Table 155. Church & Dwight Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 156. Church & Dwight Main Business
Table 157. Church & Dwight Latest Developments
Table 158. The Cooper Companies Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 159. The Cooper Companies Contraceptives Product Portfolios and Specifications
Table 160. The Cooper Companies Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 161. The Cooper Companies Main Business
Table 162. The Cooper Companies Latest Developments
Table 163. TherapeuticsMD Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 164. TherapeuticsMD Contraceptives Product Portfolios and Specifications
Table 165. TherapeuticsMD Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 166. TherapeuticsMD Main Business
Table 167. TherapeuticsMD Latest Developments
Table 168. Afaxys Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 169. Afaxys Contraceptives Product Portfolios and Specifications
Table 170. Afaxys Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 171. Afaxys Main Business
Table 172. Afaxys Latest Developments
Table 173. Mithra Pharmaceuticals Basic Information, Contraceptives Manufacturing Base, Sales Area and Its Competitors
Table 174. Mithra Pharmaceuticals Contraceptives Product Portfolios and Specifications
Table 175. Mithra Pharmaceuticals Contraceptives Sales (M Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 176. Mithra Pharmaceuticals Main Business
Table 177. Mithra Pharmaceuticals Latest Developments
List of Figures
Figure 1. Picture of Contraceptives
Figure 2. Contraceptives Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Contraceptives Sales Growth Rate 2019-2030 (M Units)
Figure 7. Global Contraceptives Revenue Growth Rate 2019-2030 ($ Millions)
Figure 8. Contraceptives Sales by Region (2019, 2023 & 2030) & ($ Millions)
Figure 9. Product Picture of Pills
Figure 10. Product Picture of Injectable
Figure 11. Product Picture of Condoms
Figure 12. Product Picture of Vaginal Rings
Figure 13. Product Picture of IUDs
Figure 14. Product Picture of Subdermal Implants
Figure 15. Product Picture of Others
Figure 16. Global Contraceptives Sales Market Share by Type in 2023
Figure 17. Global Contraceptives Revenue Market Share by Type (2019-2024)
Figure 18. Contraceptives Consumed in 15-24 years
Figure 19. Global Contraceptives Market: 15-24 years (2019-2024) & (M Units)
Figure 20. Contraceptives Consumed in 25-34 years
Figure 21. Global Contraceptives Market: 25-34 years (2019-2024) & (M Units)
Figure 22. Contraceptives Consumed in 35-44 years
Figure 23. Global Contraceptives Market: 35-44 years (2019-2024) & (M Units)
Figure 24. Contraceptives Consumed in Above 44 years
Figure 25. Global Contraceptives Market: Above 44 years (2019-2024) & (M Units)
Figure 26. Global Contraceptives Sales Market Share by End User (2023)
Figure 27. Global Contraceptives Revenue Market Share by End User in 2023
Figure 28. Contraceptives Sales Market by Company in 2023 (M Units)
Figure 29. Global Contraceptives Sales Market Share by Company in 2023
Figure 30. Contraceptives Revenue Market by Company in 2023 ($ Million)
Figure 31. Global Contraceptives Revenue Market Share by Company in 2023
Figure 32. Global Contraceptives Sales Market Share by Geographic Region (2019-2024)
Figure 33. Global Contraceptives Revenue Market Share by Geographic Region in 2023
Figure 34. Americas Contraceptives Sales 2019-2024 (M Units)
Figure 35. Americas Contraceptives Revenue 2019-2024 ($ Millions)
Figure 36. APAC Contraceptives Sales 2019-2024 (M Units)
Figure 37. APAC Contraceptives Revenue 2019-2024 ($ Millions)
Figure 38. Europe Contraceptives Sales 2019-2024 (M Units)
Figure 39. Europe Contraceptives Revenue 2019-2024 ($ Millions)
Figure 40. Middle East & Africa Contraceptives Sales 2019-2024 (M Units)
Figure 41. Middle East & Africa Contraceptives Revenue 2019-2024 ($ Millions)
Figure 42. Americas Contraceptives Sales Market Share by Country in 2023
Figure 43. Americas Contraceptives Revenue Market Share by Country in 2023
Figure 44. Americas Contraceptives Sales Market Share by Type (2019-2024)
Figure 45. Americas Contraceptives Sales Market Share by End User (2019-2024)
Figure 46. United States Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 47. Canada Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 48. Mexico Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 49. Brazil Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 50. APAC Contraceptives Sales Market Share by Region in 2023
Figure 51. APAC Contraceptives Revenue Market Share by Regions in 2023
Figure 52. APAC Contraceptives Sales Market Share by Type (2019-2024)
Figure 53. APAC Contraceptives Sales Market Share by End User (2019-2024)
Figure 54. China Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 55. Japan Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 56. South Korea Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 57. Southeast Asia Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 58. India Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 59. Australia Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 60. China Taiwan Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 61. Europe Contraceptives Sales Market Share by Country in 2023
Figure 62. Europe Contraceptives Revenue Market Share by Country in 2023
Figure 63. Europe Contraceptives Sales Market Share by Type (2019-2024)
Figure 64. Europe Contraceptives Sales Market Share by End User (2019-2024)
Figure 65. Germany Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 66. France Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 67. UK Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 68. Italy Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 69. Russia Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 70. Middle East & Africa Contraceptives Sales Market Share by Country in 2023
Figure 71. Middle East & Africa Contraceptives Revenue Market Share by Country in 2023
Figure 72. Middle East & Africa Contraceptives Sales Market Share by Type (2019-2024)
Figure 73. Middle East & Africa Contraceptives Sales Market Share by End User (2019-2024)
Figure 74. Egypt Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 75. South Africa Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 76. Israel Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 77. Turkey Contraceptives Revenue Growth 2019-2024 ($ Millions)
Figure 78. GCC C
Global Drugs for Vulvovaginal Candidiasis Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 119
According to our LPI (LP Information) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at US$ 798.8 million in 2023. With growing demand in downstream market, the Drugs for Vulvovaginal Candidiasis is forecast to a readjusted size of US$ 890 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Drugs for Vulvovaginal Candidiasis market. Drugs for Vulvovaginal Candidiasis are expected t......
Global Bacterial Vaginosis Drug Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 132
According to our LPI (LP Information) latest study, the global Bacterial Vaginosis Drug market size was valued at US$ 896.6 million in 2023. With growing demand in downstream market, the Bacterial Vaginosis Drug is forecast to a readjusted size of US$ 1111.1 million by 2030 with a CAGR of 3.1% during review period.
The research report highlights the growth potential of the global Bacterial Vaginosis Drug market. Bacterial Vaginosis Drug are expected to show stable growth in the future ma......
Global Contraceptives Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 141
According to our LPI (LP Information) latest study, the global Contraceptives market size was valued at US$ 1870.3 million in 2023. With growing demand in downstream market, the Contraceptives is forecast to a readjusted size of US$ 2237.4 million by 2030 with a CAGR of 2.6% during review period.
The research report highlights the growth potential of the global Contraceptives market. Contraceptives are expected to show stable growth in the future market. However, product differentiation,......
Global Drugs for Vulvovaginal Candidiasis Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Published: 01-Jan-2024 Price: US 3480 Onwards Pages: 108
According to our (Global Info Research) latest study, the global Drugs for Vulvovaginal Candidiasis market size was valued at USD 840.2 million in 2023 and is forecast to a readjusted size of USD 928.4 million by 2030 with a CAGR of 1.4% during review period.
The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cu......
Global Menopausal Hot Flashes Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 28-Dec-2023 Price: US 3380 Onwards Pages: 99
Market Overview of Global Menopausal Hot Flashes market:
According to our latest research, the global Menopausal Hot Flashes market looks promising in the next 5 years. As of 2022, the global Menopausal Hot Flashes market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Hot flashes during menopause are symptoms of menopause. They refer to the warmth that occurs during the transition period of ......
Global Bacterial Vaginosis Drug Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 139
Report Overview:
This report studies the Bacterial Vaginosis Drug market, Bacterial Vaginosis Drug is used for the treatment of Bacterial Vaginosis (BV), which also known as vaginal bacteriosis or Gardnerella vaginitis, a disease of the vagina caused by excessive bacteria. This report includes metronidazole, clindamycin drug and other drugs.
The Global Bacterial Vaginosis Drug Market Size was estimated at USD 916.50 million in 2022 and is projected to reach USD 1127.18 million by 202......
Global Drugs for Vulvovaginal Candidiasis Market Research Report 2024 (Status and Outlook)
Published: 15-Dec-2023 Price: US 3200 Onwards Pages: 122
Report Overview:
The cell wall of Candida is a complex glycoprotein that depends on the biosynthesis of ergosterol. Azole compounds, found in antimycotic drugs, are believed to block ergosterol production, allowing topical antimycotics to achieve cure rates in excess of 80%. The only oral azole agent approved for this indication by the US Food and Drug Administration (FDA) is fluconazole, which also achieves a high cure rate. Therapeutic concentrations are found in vaginal secretions for a......
Global Bacterial Vaginosis Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 05-Dec-2023 Price: US 3380 Onwards Pages: 108
Market Overview of Global Bacterial Vaginosis Drug market:
According to our latest research, the global Bacterial Vaginosis Drug market looks promising in the next 5 years. As of 2022, the global Bacterial Vaginosis Drug market was estimated at USD 972.77 million, and it's anticipated to reach USD 1215.68 million in 2028, with a CAGR of 3.79% during the forecast years.
Bacterial vaginosis (BV), also known as bacterial vaginosis, non-specific vaginitis is a disease that occurs......
Global Tocolysis Drugs Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 30-Nov-2023 Price: US 3380 Onwards Pages: 123
Market Overview of Global Tocolysis Drugs market:
According to our latest research, the global Tocolysis Drugs market looks promising in the next 5 years. As of 2022, the global Tocolysis Drugs market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Tocolytics are medications used to suppress premature labor. Tocolytic therapy is provided when delivery would result in premature birth, postponi......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
